Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 17, Issue 6, Pages 2078
Publisher
MDPI AG
Online
2020-03-20
DOI
10.3390/ijerph17062078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1
- (2020) Preeti Narayan et al. CLINICAL CANCER RESEARCH
- Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer
- (2020) Jiaxuan He et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer
- (2020) Jimena G. Dancy et al. Science Advances
- Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
- (2019) Wei-Siang Liao et al. Acta Biomaterialia
- Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women
- (2019) Tess O’Meara et al. BREAST CANCER RESEARCH AND TREATMENT
- Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
- (2019) Wijden Mahfoudh et al. Journal of Translational Medicine
- Hyaluronic acid-coated pH sensitive poly (β-amino Ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment
- (2019) Yingqi Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling
- (2019) Eunkyung Lee et al. Redox Biology
- Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion
- (2019) Yajing Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
- (2019) My-my Huynh et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
- (2019) Liuwan Zhao et al. JOURNAL OF CONTROLLED RELEASE
- Light-Activated Core–Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
- (2018) Qingshuo Meng et al. ACS Nano
- Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
- (2018) Y Bareche et al. ANNALS OF ONCOLOGY
- Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
- (2018) Ruijing Liang et al. BIOMATERIALS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Nanocomposites: suitable alternatives as antimicrobial agents
- (2018) Rupy Kaur Matharu et al. NANOTECHNOLOGY
- Molecular Subtypes and Local-Regional Control of Breast Cancer
- (2018) Simona Maria Fragomeni et al. Surgical Oncology Clinics of North America
- A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
- (2018) Zhixian Liu et al. Translational Oncology
- The new TNM-based staging of breast cancer
- (2018) Gábor Cserni et al. VIRCHOWS ARCHIV
- Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
- (2018) Jaison Jeevanandam et al. Beilstein Journal of Nanotechnology
- Artificial intelligence, machine learning and the evolution of healthcare
- (2018) L. D. Jones et al. Bone & Joint Research
- The WNT10B network is associated with survival and metastases in chemoresistant triple-negative breast cancer
- (2018) Ikbale El Ayachi et al. CANCER RESEARCH
- ZD2-Engineered Gold Nanostar@Metal-Organic Framework Nanoprobes for T1 -Weighted Magnetic Resonance Imaging and Photothermal Therapy Specifically Toward Triple-Negative Breast Cancer
- (2018) Luyun Zhang et al. Advanced Healthcare Materials
- Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
- (2017) Jörgen Elgqvist INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The application of aptamer 5TR1 in triple negative breast cancer target therapy
- (2017) Shayang Luo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNAs in the prognosis of triple-negative breast cancer
- (2017) Lingshuang Lü et al. MEDICINE
- Integrated analysis of the potential roles of miRNA-mRNA networks in triple negative breast cancer
- (2017) Huiru Zhu et al. Molecular Medicine Reports
- Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience
- (2017) Marcus Vetter et al. Oncotarget
- Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
- (2017) Guilhem Bousquet et al. Oncotarget
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Artificial intelligence in healthcare: past, present and future
- (2017) Fei Jiang et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy
- (2016) Jilian R. Melamed et al. ACS Nano
- Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices
- (2016) Jina Ko et al. ANALYST
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells
- (2016) Manisha Ahir et al. BIOMATERIALS
- Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
- (2016) Na Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Hyperthermia using nanoparticles – Promises and pitfalls
- (2016) Punit Kaur et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Molecular Classification of Triple-Negative Breast Cancer
- (2016) Sung Gwe Ahn et al. Journal of Breast Cancer
- Evaluation of treatment outcomes of triple-negative breast cancer
- (2016) Mustafa Akin et al. Journal of Cancer Research and Therapeutics
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials
- (2016) Anne Lynn S. Chang et al. Orphanet Journal of Rare Diseases
- Notch signaling: its roles and therapeutic potential in hematological malignancies
- (2016) Yisu Gu et al. Oncotarget
- Triple-negative breast cancer: is there a treatment on the horizon?
- (2016) Hui Yao et al. Oncotarget
- Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans
- (2016) Jie-Zhi Cheng et al. Scientific Reports
- The hedgehog pathway in triple-negative breast cancer
- (2016) Joyce G. Habib et al. Cancer Medicine
- Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers
- (2015) Yu Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives
- (2015) Lin-Wei Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review
- (2015) Sergio Maluta et al. Breast Care
- Therapeutic targets of triple-negative breast cancer: a review
- (2015) Vinayak S Jamdade et al. BRITISH JOURNAL OF PHARMACOLOGY
- Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
- (2015) Nianhang Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
- (2015) Andrea Mathe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells
- (2015) Dinesh Vyas et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Anti-PD-L1 for metastatic triple-negative breast cancer
- (2015) Josefine Gibson LANCET ONCOLOGY
- Near infrared light-actuated gold nanorods with cisplatin–polypeptide wrapping for targeted therapy of triple negative breast cancer
- (2015) Bing Feng et al. Nanoscale
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer
- (2015) Hong-Mei Zheng et al. TUMOR BIOLOGY
- Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances
- (2015) Jasmine M. Miller-Kleinhenz et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
- (2015) Katarzyna Tomczak et al. Wspolczesna Onkologia-Contemporary Oncology
- Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
- (2015) Yu-Chun Hsiao et al. Oncotarget
- Analysis of the In Vivo and In Vitro Effects of Photodynamic Therapy on Breast Cancer by Using a Sensitizer, Sinoporphyrin Sodium
- (2015) Xiaobing Wang et al. Theranostics
- Magnetic Nanoparticles in Cancer Theranostics
- (2015) Oliviero L. Gobbo et al. Theranostics
- Cannabinoids as therapeutic agents in cancer: current status and future implications
- (2015) Bandana Chakravarti et al. Oncotarget
- Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells
- (2014) Ciceron Ayala-Orozco et al. ACS Nano
- Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
- (2014) J. M. Nabholtz et al. ANNALS OF ONCOLOGY
- Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
- (2014) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- FRET Enhanced Fluorescent Nanodiamonds
- (2014) Rafal Fudala et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications
- (2014) Chuang Chen et al. International Journal of Nanomedicine
- Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
- (2014) Sheng-Rong Sun et al. International Journal of Nanomedicine
- Nanopharmaceuticals (part 1): products on the market
- (2014) Volkmar Weissig et al. International Journal of Nanomedicine
- Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors
- (2014) Ciceron Ayala-Orozco et al. JOURNAL OF CONTROLLED RELEASE
- Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
- (2014) Peng Guo et al. MOLECULAR PHARMACEUTICS
- Nanodiamond–Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells
- (2014) Tan-Boon Toh et al. MOLECULAR PHARMACEUTICS
- Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
- (2014) Elvin Blanco et al. MOLECULAR THERAPY
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Thermosensitive Liposome Formulated Indocyanine Green for Near-Infrared Triggered Photodynamic Therapy: In Vivo Evaluation for Triple-Negative Breast Cancer
- (2014) Colby S. Shemesh et al. PHARMACEUTICAL RESEARCH
- ICAM-1 as a molecular target for triple negative breast cancer
- (2014) P. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) H. Wimberly et al. Cancer Immunology Research
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
- (2013) B. Gerber et al. ANNALS OF ONCOLOGY
- Wnt signaling in triple negative breast cancer is associated with metastasis
- (2013) Nandini Dey et al. BMC CANCER
- Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer
- (2013) Rachel M. Layman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
- (2013) Miguel Martín et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
- (2013) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol
- (2013) A. Ruiz et al. Nanoscale
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
- (2013) Luciano Cascione et al. PLoS One
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
- (2013) Koichiro Hayashi et al. Theranostics
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Single-stranded DNA (ssDNA) production in DNA aptamer generation
- (2012) Citartan Marimuthu et al. ANALYST
- Imaging of triple-negative breast cancer
- (2012) B. E. Dogan et al. ANNALS OF ONCOLOGY
- The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
- (2012) Mike De Vos et al. BIOCHEMICAL PHARMACOLOGY
- Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma
- (2012) J Kim et al. BRITISH JOURNAL OF RADIOLOGY
- mTOR inhibitors in cancer therapy
- (2012) Yekaterina Y. Zaytseva et al. CANCER LETTERS
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Biological applications of magnetic nanoparticles
- (2012) Miriam Colombo et al. CHEMICAL SOCIETY REVIEWS
- Targeting the Hedgehog signaling pathway for cancer therapy
- (2012) Yiwei Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment
- (2012) Sook Ryun Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The Effect of Sodium Dodecyl Sulfate (SDS) and Cetyltrimethylammonium Bromide (CTAB) on the Properties of ZnO Synthesized by Hydrothermal Method
- (2012) Donya Ramimoghadam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Radiofrequency Ablation in the Management of Unresectable Intrahepatic Cholangiocarcinoma
- (2012) Ying Fu et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP-1 Activation--Bringing the Pieces Together
- (2012) J.-P. Gagne et al. SCIENCE
- Targeting EGFR in Triple Negative Breast Cancer
- (2012) Naoto T. Ueno et al. Journal of Cancer
- Combining Notch inhibition with current therapies for breast cancer treatment
- (2012) Keith Brennan et al. Therapeutic Advances in Medical Oncology
- Purification and Magnetic Interrogation of Hybrid Au-Fe3O4 and FePt-Fe3O4 Nanoparticles
- (2011) Jacob S. Beveridge et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2011) S. Aebi et al. ANNALS OF ONCOLOGY
- Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
- (2011) J. E. Panoff et al. BREAST CANCER RESEARCH AND TREATMENT
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
- (2011) Leif W. Ellisen CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey
- (2011) S. Verma et al. Current Oncology
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
- (2011) Suzanne A. Eccles INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy
- (2011) Bassam S. Abdulkarim et al. JOURNAL OF CLINICAL ONCOLOGY
- A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
- (2011) A. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer
- (2011) Lara Milane et al. Nanomedicine-Nanotechnology Biology and Medicine
- Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system
- (2011) Weiqi Zhang et al. Nanoscale
- Methods for L-ribooligonucleotide sequence determination using LCMS
- (2011) John J. Turner et al. NUCLEIC ACIDS RESEARCH
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
- (2011) E. K. Chow et al. Science Translational Medicine
- Locoregional Recurrence in Patients With Triple-Negative Breast Cancer
- (2010) Anthony E. Dragun et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Luminescent Carbon Nanodots: Emergent Nanolights
- (2010) Sheila N. Baker et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chemotherapy and signaling
- (2010) Tetyana V. Bagnyukova et al. CANCER BIOLOGY & THERAPY
- Triple-Negative Breast Cancer
- (2010) Steven J. Isakoff CANCER JOURNAL
- Triple-Negative Breast Cancer
- (2010) Shaheenah Dawood DRUGS
- Gold nanorods as new nanochromophores for photothermal therapies
- (2010) Fulvio Ratto et al. Journal of Biophotonics
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
- (2010) Xinhui Wang et al. JNCI-Journal of the National Cancer Institute
- Single-wall carbon nanotubes assisted photothermal cancer therapy: Animal study with a murine model of squamous cell carcinoma
- (2010) Naiyan Huang et al. LASERS IN SURGERY AND MEDICINE
- β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
- (2010) Felipe C Geyer et al. MODERN PATHOLOGY
- Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
- (2010) David A. Scheinberg et al. Nature Reviews Clinical Oncology
- Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate
- (2010) C. E. Strom et al. NUCLEIC ACIDS RESEARCH
- Inorganic Nanoparticles as Protein Mimics
- (2010) Nicholas A. Kotov SCIENCE
- A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies
- (2010) Laura C. Kennedy et al. Small
- Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer
- (2009) G. Frasci et al. ANNALS OF ONCOLOGY
- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
- (2009) B. Corkery et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia
- (2009) Pol-Edern Le Renard et al. BIOMATERIALS
- Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation
- (2009) Gary M. Freedman et al. CANCER
- Multiparametric Monitoring of Tumor Response to Chemotherapy by Noninvasive Imaging
- (2009) Z. Medarova et al. CANCER RESEARCH
- The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
- (2009) Rui Benedito et al. CELL
- Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
- (2009) Farrah Kassam et al. Clinical Breast Cancer
- Review: Nanocomposites in Food Packaging
- (2009) Amit Arora et al. JOURNAL OF FOOD SCIENCE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hedgehog signalling in vascular development
- (2008) Takashi Nagase et al. ANGIOGENESIS
- Multi-functional nanocarriers to overcome tumor drug resistance
- (2008) Lara S. Jabr-Milane et al. CANCER TREATMENT REVIEWS
- ‘Triple Negative’ Breast Cancer: a New Area for Phase III Breast Cancer Clinical Trials
- (2008) L.S. Kilburn CLINICAL ONCOLOGY
- Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging
- (2008) Lily Yang et al. Journal of Biomedical Nanotechnology
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential chemotherapy side effects: What do oncologists tell parents?
- (2008) Lisa Ysela Ramirez et al. PEDIATRIC BLOOD & CANCER
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
- (2007) Alessandra Gennari et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started